Adjuvant chemotherapy for early-stage non-small-cell lung cancer. Single-centre experience and literature review
✍ Scribed by Ana Belén Custodio Carretero; José Ángel García Sáenz; José Luis González Larriba; Jana Bobokova; Antonio Calles Blanco; Florentino Hernando Trancho; Beatriz García Paredes; Laura Rodríguez Lajusticia; Eduardo Díaz-Rubio García
- Publisher
- Springer Milan
- Year
- 2008
- Tongue
- Spanish
- Weight
- 397 KB
- Volume
- 10
- Category
- Article
- ISSN
- 1699-048X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Thirty-nine patients with mediastinoscopy stage IIIA, N2 non-small cell lung cancer received two cycles of MVP (mitomycin C, vindesine, cisplatin). Responders underwent thoracotomy for resection and two further courses of MVP. Overall response rate was 64% (25/39) with three complete and 22 partial
Between 1975 and 1980, 101 patients with inoperable Stage IIIMO non-small cell lung carcinoma were entered into combined radiotherapy and chemotherapy trials at Michael Reese Hospital and University of Chicago Hospital. Sixty-four percent of the patients responded. Median survival for all patients w